Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-09-06

AUTHORS

Hyung-Jun Im, Kyoungjune Pak, Gi Jeong Cheon, Keon Wook Kang, Seong-Jang Kim, In-Joo Kim, June-Key Chung, E. Edmund Kim, Dong Soo Lee

ABSTRACT

PurposeWe conducted a comprehensive systematic review of the literature on volumetric parameters from 18F-FDG PET and a meta-analysis of the prognostic value of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) in patients with lung cancer.MethodsA systematic search of MEDLINE and EMBASE was performed using the keywords “positron emission tomography (PET)”, “lung cancer”, and “volume”. Inclusion criteria were: 18F-FDG PET used as an initial imaging tool; studies limited to non-small-cell lung cancer (NSCLC); volume measurement of lung cancer; patients who had not undergone surgery, chemotherapy, or radiotherapy before the PET scan; and studies that reported survival data. Event-free survival and overall survival were evaluated as outcomes. The impact of MTV and TLG on survival was measured in terms of the hazard ratio (HR) effect size. Data from each study were analysed using Review Manager 5.2.ResultsThirteen eligible studies including 1,581 patients were analysed. Patients with high MTV showed a worse prognosis with an HR of 2.71 (95 % CI 1.82 – 4.02, p < 0.00001) for adverse events and an HR of 2.31 (95 % CI 1.54 – 3.47, p < 0.00001) for death. Patients with high TLG also showed a worse prognosis with an HR of 2.35 (95 % CI 1.91 – 2.89, p < 0.00001) for adverse events and an HR of 2.43 (95 % CI 1.89 – 3.11, p < 0.00001) for death. The prognostic value of MTV and TLG remained significant in a subgroup analysis according to TNM stage as well as the methods for defining cut-off values and tumour delineation.ConclusionVolumetric parameters from 18F-FDG PET are significant prognostic factors for outcome in patients with NSCLC. Patients with a high MTV or TLG are at higher risk of adverse events and death. MTV and TLG were significant prognostic factors in patients with TNM stage I/II and stage III/IV NSCLC. More... »

PAGES

241-251

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-014-2903-7

DOI

http://dx.doi.org/10.1007/s00259-014-2903-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007455399

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25193652


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Im", 
        "givenName": "Hyung-Jun", 
        "id": "sg:person.01310744444.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310744444.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.412588.2", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea", 
            "Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pak", 
        "givenName": "Kyoungjune", 
        "id": "sg:person.01047567403.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047567403.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheon", 
        "givenName": "Gi Jeong", 
        "id": "sg:person.01333472502.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333472502.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Keon Wook", 
        "id": "sg:person.0761746266.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.412588.2", 
          "name": [
            "Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Seong-Jang", 
        "id": "sg:person.0631446453.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631446453.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.412588.2", 
          "name": [
            "Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "In-Joo", 
        "id": "sg:person.01323014166.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323014166.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiological Science, University of California at Irvine, California, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.266093.8", 
          "name": [
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea", 
            "Department of Radiological Science, University of California at Irvine, California, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "E. Edmund", 
        "id": "sg:person.0656745142.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656745142.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "id": "sg:person.015617314175.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13139-012-0165-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004057562", 
          "https://doi.org/10.1007/s13139-012-0165-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-013-2530-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001305874", 
          "https://doi.org/10.1007/s00259-013-2530-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-012-0604-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011120417", 
          "https://doi.org/10.1007/s12149-012-0604-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-012-2280-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042189086", 
          "https://doi.org/10.1007/s00259-012-2280-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-013-3270-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019614327", 
          "https://doi.org/10.1245/s10434-013-3270-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13139-013-0216-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037562362", 
          "https://doi.org/10.1007/s13139-013-0216-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13139-013-0260-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046932155", 
          "https://doi.org/10.1007/s13139-013-0260-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-09-06", 
    "datePublishedReg": "2014-09-06", 
    "description": "PurposeWe conducted a comprehensive systematic review of the literature on volumetric parameters from 18F-FDG PET and a meta-analysis of the prognostic value of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) in patients with lung cancer.MethodsA systematic search of MEDLINE and EMBASE was performed using the keywords \u201cpositron emission tomography (PET)\u201d, \u201clung cancer\u201d, and \u201cvolume\u201d. Inclusion criteria were: 18F-FDG PET used as an initial imaging tool; studies limited to non-small-cell lung cancer (NSCLC); volume measurement of lung cancer; patients who had not undergone surgery, chemotherapy, or radiotherapy before the PET scan; and studies that reported survival data. Event-free survival and overall survival were evaluated as outcomes. The impact of MTV and TLG on survival was measured in terms of the hazard ratio (HR) effect size. Data from each study were analysed using Review Manager 5.2.ResultsThirteen eligible studies including 1,581 patients were analysed. Patients with high MTV showed a worse prognosis with an HR of 2.71 (95\u00a0% CI 1.82\u00a0\u2013\u00a04.02, p\u2009<\u20090.00001) for adverse events and an HR of 2.31 (95\u00a0% CI 1.54\u00a0\u2013\u00a03.47, p\u2009<\u20090.00001) for death. Patients with high TLG also showed a worse prognosis with an HR of 2.35 (95\u00a0% CI 1.91\u00a0\u2013\u00a02.89, p\u2009<\u20090.00001) for adverse events and an HR of 2.43 (95\u00a0% CI 1.89\u00a0\u2013\u00a03.11, p\u2009<\u20090.00001) for death. The prognostic value of MTV and TLG remained significant in a subgroup analysis according to TNM stage as well as the methods for defining cut-off values and tumour delineation.ConclusionVolumetric parameters from 18F-FDG PET are significant prognostic factors for outcome in patients with NSCLC. Patients with a high MTV or TLG are at higher risk of adverse events and death. MTV and TLG were significant prognostic factors in patients with TNM stage I/II and stage III/IV NSCLC.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-014-2903-7", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "total lesion glycolysis", 
      "metabolic tumor volume", 
      "positron emission tomography", 
      "High metabolic tumor volume", 
      "significant prognostic factors", 
      "cell lung cancer", 
      "lung cancer", 
      "adverse events", 
      "prognostic value", 
      "prognostic factors", 
      "worse prognosis", 
      "TNM stage I/II", 
      "stage III/IV NSCLC", 
      "high total lesion glycolysis", 
      "stage I/II", 
      "initial imaging tool", 
      "event-free survival", 
      "comprehensive systematic review", 
      "volumetric parameters", 
      "overall survival", 
      "lesion glycolysis", 
      "TNM stage", 
      "subgroup analysis", 
      "eligible studies", 
      "inclusion criteria", 
      "tumor volume", 
      "high risk", 
      "PET scans", 
      "patients", 
      "systematic review", 
      "emission tomography", 
      "cancer", 
      "systematic search", 
      "survival data", 
      "NSCLC", 
      "death", 
      "prognosis", 
      "imaging tool", 
      "survival", 
      "effect size", 
      "hr", 
      "volume measurements", 
      "outcomes", 
      "ratio effect sizes", 
      "chemotherapy", 
      "EMBASE", 
      "surgery", 
      "MEDLINE", 
      "radiotherapy", 
      "PurposeWe", 
      "study", 
      "tomography", 
      "scans", 
      "factors", 
      "events", 
      "risk", 
      "glycolysis", 
      "volume", 
      "review", 
      "data", 
      "criteria", 
      "delineation", 
      "values", 
      "keywords", 
      "search", 
      "stage", 
      "literature", 
      "impact", 
      "analysis", 
      "parameters", 
      "tool", 
      "size", 
      "method", 
      "measurements", 
      "terms"
    ], 
    "name": "Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis", 
    "pagination": "241-251", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007455399"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-014-2903-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25193652"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-014-2903-7", 
      "https://app.dimensions.ai/details/publication/pub.1007455399"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_636.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-014-2903-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2903-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2903-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2903-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2903-7'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      116 URIs      101 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-014-2903-7 schema:about N11f13ed0949c4204951a0626dda4da94
2 N21c8d049b80f490d8f04f696169df346
3 N374514df363c4c0f8d2d0a5b2b6c3359
4 N5ce7626f01394b5390b6a9a787735be9
5 N6d07d01289714dc7a38bab1391a67771
6 N6ebea7628bb84f93b0b222407c159061
7 N9ced338e9d74438a80ef5a8afd37b73d
8 Ndf2b9488e2864c9db631bf2f9a69f123
9 Nf7968560c26d43ba9858b90a38beb11c
10 anzsrc-for:11
11 anzsrc-for:1112
12 schema:author N486bf7f1245943419841b5ef9f6540fa
13 schema:citation sg:pub.10.1007/s00259-012-2280-z
14 sg:pub.10.1007/s00259-013-2530-8
15 sg:pub.10.1007/s12149-012-0604-5
16 sg:pub.10.1007/s13139-012-0165-5
17 sg:pub.10.1007/s13139-013-0216-6
18 sg:pub.10.1007/s13139-013-0260-2
19 sg:pub.10.1245/s10434-013-3270-5
20 schema:datePublished 2014-09-06
21 schema:datePublishedReg 2014-09-06
22 schema:description PurposeWe conducted a comprehensive systematic review of the literature on volumetric parameters from 18F-FDG PET and a meta-analysis of the prognostic value of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) in patients with lung cancer.MethodsA systematic search of MEDLINE and EMBASE was performed using the keywords “positron emission tomography (PET)”, “lung cancer”, and “volume”. Inclusion criteria were: 18F-FDG PET used as an initial imaging tool; studies limited to non-small-cell lung cancer (NSCLC); volume measurement of lung cancer; patients who had not undergone surgery, chemotherapy, or radiotherapy before the PET scan; and studies that reported survival data. Event-free survival and overall survival were evaluated as outcomes. The impact of MTV and TLG on survival was measured in terms of the hazard ratio (HR) effect size. Data from each study were analysed using Review Manager 5.2.ResultsThirteen eligible studies including 1,581 patients were analysed. Patients with high MTV showed a worse prognosis with an HR of 2.71 (95 % CI 1.82 – 4.02, p < 0.00001) for adverse events and an HR of 2.31 (95 % CI 1.54 – 3.47, p < 0.00001) for death. Patients with high TLG also showed a worse prognosis with an HR of 2.35 (95 % CI 1.91 – 2.89, p < 0.00001) for adverse events and an HR of 2.43 (95 % CI 1.89 – 3.11, p < 0.00001) for death. The prognostic value of MTV and TLG remained significant in a subgroup analysis according to TNM stage as well as the methods for defining cut-off values and tumour delineation.ConclusionVolumetric parameters from 18F-FDG PET are significant prognostic factors for outcome in patients with NSCLC. Patients with a high MTV or TLG are at higher risk of adverse events and death. MTV and TLG were significant prognostic factors in patients with TNM stage I/II and stage III/IV NSCLC.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf Na135085785604df395f2b2a1c83f1505
26 Nd5fb0b6a67e443078f2045ca6515bca1
27 sg:journal.1297401
28 schema:keywords EMBASE
29 High metabolic tumor volume
30 MEDLINE
31 NSCLC
32 PET scans
33 PurposeWe
34 TNM stage
35 TNM stage I/II
36 adverse events
37 analysis
38 cancer
39 cell lung cancer
40 chemotherapy
41 comprehensive systematic review
42 criteria
43 data
44 death
45 delineation
46 effect size
47 eligible studies
48 emission tomography
49 event-free survival
50 events
51 factors
52 glycolysis
53 high risk
54 high total lesion glycolysis
55 hr
56 imaging tool
57 impact
58 inclusion criteria
59 initial imaging tool
60 keywords
61 lesion glycolysis
62 literature
63 lung cancer
64 measurements
65 metabolic tumor volume
66 method
67 outcomes
68 overall survival
69 parameters
70 patients
71 positron emission tomography
72 prognosis
73 prognostic factors
74 prognostic value
75 radiotherapy
76 ratio effect sizes
77 review
78 risk
79 scans
80 search
81 significant prognostic factors
82 size
83 stage
84 stage I/II
85 stage III/IV NSCLC
86 study
87 subgroup analysis
88 surgery
89 survival
90 survival data
91 systematic review
92 systematic search
93 terms
94 tomography
95 tool
96 total lesion glycolysis
97 tumor volume
98 values
99 volume
100 volume measurements
101 volumetric parameters
102 worse prognosis
103 schema:name Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis
104 schema:pagination 241-251
105 schema:productId N1f69a007274141458eb152390c1522e3
106 N2890e0a84a884742a272919e8c64ecbe
107 N6b86e06b8c174d8a8657245ba0bccc1f
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007455399
109 https://doi.org/10.1007/s00259-014-2903-7
110 schema:sdDatePublished 2022-10-01T06:40
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher Nd1fd76204a3e4ae0942481b0067ba6fa
113 schema:url https://doi.org/10.1007/s00259-014-2903-7
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N06e3a2330a36483784153c441816de85 rdf:first sg:person.01333472502.31
118 rdf:rest N715f943ee8b54d43988cc1b6f0874d6a
119 N119ed2e51b2547659d5353b8920b3049 rdf:first sg:person.01047567403.71
120 rdf:rest N06e3a2330a36483784153c441816de85
121 N11f13ed0949c4204951a0626dda4da94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Female
123 rdf:type schema:DefinedTerm
124 N16fe3a18762d4745af2ac23ce0491861 rdf:first sg:person.01323014166.25
125 rdf:rest N480dc0157fee45dfb4958cca3daa7bf2
126 N1f69a007274141458eb152390c1522e3 schema:name pubmed_id
127 schema:value 25193652
128 rdf:type schema:PropertyValue
129 N21c8d049b80f490d8f04f696169df346 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Radiopharmaceuticals
131 rdf:type schema:DefinedTerm
132 N2890e0a84a884742a272919e8c64ecbe schema:name dimensions_id
133 schema:value pub.1007455399
134 rdf:type schema:PropertyValue
135 N374514df363c4c0f8d2d0a5b2b6c3359 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Humans
137 rdf:type schema:DefinedTerm
138 N480dc0157fee45dfb4958cca3daa7bf2 rdf:first sg:person.0751347234.39
139 rdf:rest Ne77d66f335d3496bae28a754115fbcf9
140 N486bf7f1245943419841b5ef9f6540fa rdf:first sg:person.01310744444.16
141 rdf:rest N119ed2e51b2547659d5353b8920b3049
142 N5ce7626f01394b5390b6a9a787735be9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Lung Neoplasms
144 rdf:type schema:DefinedTerm
145 N6b86e06b8c174d8a8657245ba0bccc1f schema:name doi
146 schema:value 10.1007/s00259-014-2903-7
147 rdf:type schema:PropertyValue
148 N6d07d01289714dc7a38bab1391a67771 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Fluorodeoxyglucose F18
150 rdf:type schema:DefinedTerm
151 N6ebea7628bb84f93b0b222407c159061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Positron-Emission Tomography
153 rdf:type schema:DefinedTerm
154 N715f943ee8b54d43988cc1b6f0874d6a rdf:first sg:person.0761746266.86
155 rdf:rest Nf22080d169d94ec18a391634e0da6f33
156 N9ced338e9d74438a80ef5a8afd37b73d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Predictive Value of Tests
158 rdf:type schema:DefinedTerm
159 Na135085785604df395f2b2a1c83f1505 schema:issueNumber 2
160 rdf:type schema:PublicationIssue
161 Nb882df04bbf74dbe8098020a213eaa95 rdf:first sg:person.015617314175.88
162 rdf:rest rdf:nil
163 Nd1fd76204a3e4ae0942481b0067ba6fa schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Nd5fb0b6a67e443078f2045ca6515bca1 schema:volumeNumber 42
166 rdf:type schema:PublicationVolume
167 Ndf2b9488e2864c9db631bf2f9a69f123 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Carcinoma, Non-Small-Cell Lung
169 rdf:type schema:DefinedTerm
170 Ne77d66f335d3496bae28a754115fbcf9 rdf:first sg:person.0656745142.66
171 rdf:rest Nb882df04bbf74dbe8098020a213eaa95
172 Nf22080d169d94ec18a391634e0da6f33 rdf:first sg:person.0631446453.19
173 rdf:rest N16fe3a18762d4745af2ac23ce0491861
174 Nf7968560c26d43ba9858b90a38beb11c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Male
176 rdf:type schema:DefinedTerm
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
181 schema:name Oncology and Carcinogenesis
182 rdf:type schema:DefinedTerm
183 sg:journal.1297401 schema:issn 1619-7070
184 1619-7089
185 schema:name European Journal of Nuclear Medicine and Molecular Imaging
186 schema:publisher Springer Nature
187 rdf:type schema:Periodical
188 sg:person.01047567403.71 schema:affiliation grid-institutes:grid.412588.2
189 schema:familyName Pak
190 schema:givenName Kyoungjune
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047567403.71
192 rdf:type schema:Person
193 sg:person.01310744444.16 schema:affiliation grid-institutes:None
194 schema:familyName Im
195 schema:givenName Hyung-Jun
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310744444.16
197 rdf:type schema:Person
198 sg:person.01323014166.25 schema:affiliation grid-institutes:grid.412588.2
199 schema:familyName Kim
200 schema:givenName In-Joo
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323014166.25
202 rdf:type schema:Person
203 sg:person.01333472502.31 schema:affiliation grid-institutes:grid.31501.36
204 schema:familyName Cheon
205 schema:givenName Gi Jeong
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333472502.31
207 rdf:type schema:Person
208 sg:person.015617314175.88 schema:affiliation grid-institutes:grid.31501.36
209 schema:familyName Lee
210 schema:givenName Dong Soo
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88
212 rdf:type schema:Person
213 sg:person.0631446453.19 schema:affiliation grid-institutes:grid.412588.2
214 schema:familyName Kim
215 schema:givenName Seong-Jang
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631446453.19
217 rdf:type schema:Person
218 sg:person.0656745142.66 schema:affiliation grid-institutes:grid.266093.8
219 schema:familyName Kim
220 schema:givenName E. Edmund
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656745142.66
222 rdf:type schema:Person
223 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
224 schema:familyName Chung
225 schema:givenName June-Key
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
227 rdf:type schema:Person
228 sg:person.0761746266.86 schema:affiliation grid-institutes:grid.31501.36
229 schema:familyName Kang
230 schema:givenName Keon Wook
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86
232 rdf:type schema:Person
233 sg:pub.10.1007/s00259-012-2280-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1042189086
234 https://doi.org/10.1007/s00259-012-2280-z
235 rdf:type schema:CreativeWork
236 sg:pub.10.1007/s00259-013-2530-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001305874
237 https://doi.org/10.1007/s00259-013-2530-8
238 rdf:type schema:CreativeWork
239 sg:pub.10.1007/s12149-012-0604-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011120417
240 https://doi.org/10.1007/s12149-012-0604-5
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/s13139-012-0165-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004057562
243 https://doi.org/10.1007/s13139-012-0165-5
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/s13139-013-0216-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037562362
246 https://doi.org/10.1007/s13139-013-0216-6
247 rdf:type schema:CreativeWork
248 sg:pub.10.1007/s13139-013-0260-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046932155
249 https://doi.org/10.1007/s13139-013-0260-2
250 rdf:type schema:CreativeWork
251 sg:pub.10.1245/s10434-013-3270-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019614327
252 https://doi.org/10.1245/s10434-013-3270-5
253 rdf:type schema:CreativeWork
254 grid-institutes:None schema:alternateName Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea
255 schema:name Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea
256 Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea
257 rdf:type schema:Organization
258 grid-institutes:grid.266093.8 schema:alternateName Department of Radiological Science, University of California at Irvine, California, CA, USA
259 schema:name Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea
260 Department of Radiological Science, University of California at Irvine, California, CA, USA
261 rdf:type schema:Organization
262 grid-institutes:grid.31501.36 schema:alternateName Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea
263 schema:name Cancer Research Institute, Seoul National University Hospital, Seoul, South Korea
264 Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul, South Korea
265 Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea
266 rdf:type schema:Organization
267 grid-institutes:grid.412588.2 schema:alternateName Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
268 schema:name Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
269 Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, 110-744, Seoul, Jongno-gu, South Korea
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...